 DURHAM, N.C., March 12, 2021 GLOBE NEWSWIRE -- Precision BioSciences, Inc. Nasdaq: DTIL, a clinical stage biotechnology company, today announced it will publish fourth quarter and fiscal year 2020 financial results and provide a business update on Thursday, March 18, 2021. 